Clinical Profile of a Patient After MI and ACVA Based on Outpatient Register Data
NCT ID: NCT07159698
Last Updated: 2025-11-24
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ENROLLING_BY_INVITATION
1520 participants
OBSERVATIONAL
2025-01-01
2026-06-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
To Develop and Introduce Into Polyclinic Practice a Register of Patients with Experience of Myocardial Infarction and Acute Cerebrovascular Disease
NCT06815913
Myocardial Infarction in the Elderly
NCT06860646
Short and Long Term Outcomes of Acute Coronary Syndrome in Patients With Non Obstructive Coronary Atherosclerosis
NCT02655718
Evaluation of Novel Risk Factors and Clinical Outcomes of Acute Myocardial Infarction
NCT02641184
The Problem of Incomplete Myocardial Revascularization in Percutaneous Coronary Intervention in Patients With NSTEMI
NCT04490928
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The objective of the study: to determine the features of clinical and epidemiological characteristics and parameters of laboratory and instrumental studies, the profile of cardiovascular risk factors in patients with a history of MI and ACVA, and to establish their adherence to treatment before and after the reference event over a 12-year follow-up period.
Materials and methods. The investigators analyzed the data of 410 patients who applied to an outpatient and polyclinic healthcare organization between January 1, 2019, and December 31, 2022, with confirmed acute (recurrent) myocardial infarction and/or cerebral infarction that occurred between January 1, 2010, and December 31, 2019. Patients were included in the register after establishing their vital status as of January 1, 2020. The data of records and reports from healthcare organizations (forms 025/u, 131-u) and electronic outpatient records of medical information systems (MIS) from outpatient polyclinic institutions (OPI) were used. The results of the retrospective stage analysis of the study and the electronic patient database from the information and analytical system "Register of MI/ACVA" were presented. Standard methods of descriptive and analytical statistics, statistical software packages (SPSS, SAS, STATISTIKA 10, Stata) and programming languages (R, Python) were used.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
OTHER
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
myocardial infarction (MI)
Patients with a history of MI of any remoteness; visit to the outpatient clinic for any reason during the period from January 1, 2019, to December 31, 2022; age 18 years or older; the presence of informed consent for the processing of personal data in the outpatient medical record; and permanent residence in the city where the register is being established.
No interventions assigned to this group
acute cerebrovascular accident (ACVA)
Patients with a history of ACVA of any remoteness; visit to the outpatient clinic for any reason during the period from January 1, 2019, to December 31, 2022; age 18 years or older; the presence of informed consent for the processing of personal data in the outpatient medical record; and permanent residence in the city where the register is being established.
No interventions assigned to this group
acute cerebrovascular accident + myocardial infarction (ACVA+MI)
Patients with a history of MI and ACVA of any remoteness; visit to the outpatient clinic for any reason during the period from January 1, 2019, to December 31, 2022; age 18 years or older; the presence of informed consent for the processing of personal data in the outpatient medical record; and permanent residence in the city where the register is being established.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* visit to the outpatient clinic for any reason during the period from January 1, 2019, to December 31, 2022;
* age 18 years or older;
* the presence of informed consent for the processing of personal data in the outpatient medical record;
* permanent residence in the city where the register is being established.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Belarusian State Medical University
OTHER
State Institution "Republican Scientific and Practical Center" Cardiology, Belarus
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Pabivantsava Natallia
Head of the Laboratories of Comorbid Cardiology, RSPC Cardiology, Ph.D (Medicine)
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Elena Grigorenko, Ph.D
Role: STUDY_CHAIR
Republican Scientific and Practical Center of Cardiology
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Republican Scientific and Practical Center of Cardiology
Minsk, , Belarus
Countries
Review the countries where the study has at least one active or historical site.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
20250326
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.